Hancock Whitney Corp Sells 1,402 Shares of Agilent Technologies, Inc. (NYSE:A)

Hancock Whitney Corp trimmed its position in Agilent Technologies, Inc. (NYSE:A) by 6.6% in the second quarter, according to its most recent filing with the SEC. The fund owned 19,992 shares of the medical research company’s stock after selling 1,402 shares during the period. Hancock Whitney Corp’s holdings in Agilent Technologies were worth $2,592,000 as of its most recent filing with the SEC.

Several other hedge funds also recently modified their holdings of A. Livelsberger Financial Advisory bought a new stake in Agilent Technologies during the 4th quarter worth approximately $26,000. Crewe Advisors LLC increased its holdings in Agilent Technologies by 114.8% in the second quarter. Crewe Advisors LLC now owns 189 shares of the medical research company’s stock valued at $25,000 after purchasing an additional 101 shares during the period. Ridgewood Investments LLC bought a new position in Agilent Technologies during the 2nd quarter worth $29,000. Rise Advisors LLC lifted its holdings in Agilent Technologies by 527.8% during the 1st quarter. Rise Advisors LLC now owns 226 shares of the medical research company’s stock worth $33,000 after buying an additional 190 shares during the period. Finally, YHB Investment Advisors Inc. bought a new stake in shares of Agilent Technologies in the 1st quarter valued at about $34,000. Institutional investors and hedge funds own 87.42% of the company’s stock.

Analyst Ratings Changes

A has been the subject of a number of analyst reports. Wolfe Research downgraded Agilent Technologies from an “outperform” rating to a “peer perform” rating in a research report on Thursday, June 27th. TD Cowen boosted their price target on shares of Agilent Technologies from $153.00 to $160.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. Robert W. Baird reduced their price objective on shares of Agilent Technologies from $147.00 to $136.00 and set an “outperform” rating on the stock in a research note on Thursday, May 30th. JPMorgan Chase & Co. lowered their target price on shares of Agilent Technologies from $165.00 to $155.00 and set an “overweight” rating for the company in a research note on Thursday, May 30th. Finally, UBS Group boosted their price target on Agilent Technologies from $141.00 to $150.00 and gave the company a “neutral” rating in a research note on Thursday, August 22nd. One research analyst has rated the stock with a sell rating, six have issued a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat.com, Agilent Technologies currently has an average rating of “Moderate Buy” and a consensus price target of $141.60.

Agilent Technologies Trading Down 1.3 %

NYSE:A opened at $140.09 on Friday. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.78 and a quick ratio of 1.37. The firm has a 50-day moving average of $137.87 and a 200-day moving average of $139.21. The company has a market cap of $40.87 billion, a PE ratio of 33.12, a PEG ratio of 6.43 and a beta of 1.05. Agilent Technologies, Inc. has a one year low of $96.80 and a one year high of $155.35.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Wednesday, August 21st. The medical research company reported $1.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.26 by $0.06. Agilent Technologies had a return on equity of 25.26% and a net margin of 21.75%. The business had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.56 billion. During the same quarter in the prior year, the company posted $1.43 earnings per share. Agilent Technologies’s revenue was down 5.6% compared to the same quarter last year. As a group, equities research analysts expect that Agilent Technologies, Inc. will post 5.24 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, October 23rd. Investors of record on Tuesday, October 1st will be given a dividend of $0.236 per share. This represents a $0.94 dividend on an annualized basis and a dividend yield of 0.67%. The ex-dividend date of this dividend is Tuesday, October 1st. Agilent Technologies’s payout ratio is currently 22.22%.

Insider Buying and Selling

In other news, CEO Padraig Mcdonnell sold 1,958 shares of the company’s stock in a transaction that occurred on Thursday, August 22nd. The stock was sold at an average price of $145.00, for a total value of $283,910.00. Following the completion of the transaction, the chief executive officer now directly owns 24,118 shares of the company’s stock, valued at $3,497,110. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. 0.33% of the stock is owned by corporate insiders.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.